(Q72669177)
Statements
Expansion of peripheral blood natural killer cells correlates with clinical outcome in cancer patients receiving recombinant subcutaneous interleukin-2 and interferon-alpha-2 (English)
J Atzpodien
H Kirchner
A Körfer
M Hadam
A Schomburg
T Menzel
M Deckert
A Franzke
M Volkenandt
1 January 1993